Jw Pharmac (001060) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.046x

Based on the latest financial reports, Jw Pharmac (001060) has a cash flow conversion efficiency ratio of 0.046x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩17.50 Billion ≈ $11.86 Million USD) by net assets (₩381.78 Billion ≈ $258.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Jw Pharmac (001060) total market value for the company's overall valuation and market capitalisation.

Jw Pharmac - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Jw Pharmac's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jw Pharmac Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jw Pharmac ranked by their cash flow conversion efficiency. Explore 001060 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Testa Residencial SOCIMI S.A. MC:YTST	N/A
Studio Dragon Corporation KQ:253450	0.024x
29METALS Ltd AU:29M	0.051x
Brightstar Resources Ltd AU:BTR	-0.075x
Multiconsult AS OL:MULTI	0.212x
VITZROCELL Co.Ltd KQ:082920	0.041x
AirAsia X Bhd KLSE:5238	-4.848x
Leaguer Shenzhen MicroElectronics Corp SHG:688589	0.014x

Annual Cash Flow Conversion Efficiency for Jw Pharmac (2001–2025)

The table below shows the annual cash flow conversion efficiency of Jw Pharmac from 2001 to 2025. View Jw Pharmac stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩369.37 Billion ≈ $250.32 Million	₩96.40 Billion ≈ $65.33 Million	0.261x	+8.31%
2024-12-31	₩329.49 Billion ≈ $223.29 Million	₩79.39 Billion ≈ $53.80 Million	0.241x	-26.62%
2023-12-31	₩265.44 Billion ≈ $179.89 Million	₩87.16 Billion ≈ $59.07 Million	0.328x	+30.59%
2022-12-31	₩225.76 Billion ≈ $152.99 Million	₩56.76 Billion ≈ $38.47 Million	0.251x	+161.57%
2021-12-31	₩188.54 Billion ≈ $127.77 Million	₩18.12 Billion ≈ $12.28 Million	0.096x	-68.37%
2020-12-31	₩207.47 Billion ≈ $140.60 Million	₩63.05 Billion ≈ $42.73 Million	0.304x	+25.93%
2019-12-31	₩230.09 Billion ≈ $155.93 Million	₩55.53 Billion ≈ $37.63 Million	0.241x	+20.47%
2018-12-31	₩260.11 Billion ≈ $176.27 Million	₩52.11 Billion ≈ $35.31 Million	0.200x	+62.17%
2017-12-31	₩270.78 Billion ≈ $183.50 Million	₩33.45 Billion ≈ $22.67 Million	0.124x	+406.54%
2016-12-31	₩276.31 Billion ≈ $187.25 Million	₩6.74 Billion ≈ $4.57 Million	0.024x	+231.67%
2015-12-31	₩225.41 Billion ≈ $152.75 Million	₩-4.17 Billion ≈ $-2.83 Million	-0.019x	-156.95%
2014-12-31	₩223.83 Billion ≈ $151.68 Million	₩7.28 Billion ≈ $4.93 Million	0.033x	-65.14%
2013-12-31	₩200.74 Billion ≈ $136.04 Million	₩18.72 Billion ≈ $12.69 Million	0.093x	-76.23%
2012-12-31	₩163.66 Billion ≈ $110.91 Million	₩64.21 Billion ≈ $43.52 Million	0.392x	+1233.92%
2006-12-31	₩172.48 Billion ≈ $116.89 Million	₩5.07 Billion ≈ $3.44 Million	0.029x	-95.00%
2005-12-31	₩119.44 Billion ≈ $80.95 Million	₩70.25 Billion ≈ $47.61 Million	0.588x	+367.61%
2004-12-31	₩119.39 Billion ≈ $80.91 Million	₩15.02 Billion ≈ $10.18 Million	0.126x	-16.92%
2003-12-31	₩112.60 Billion ≈ $76.31 Million	₩17.05 Billion ≈ $11.55 Million	0.151x	-46.93%
2002-12-31	₩100.72 Billion ≈ $68.26 Million	₩28.74 Billion ≈ $19.47 Million	0.285x	-43.68%
2001-12-31	₩88.92 Billion ≈ $60.26 Million	₩45.04 Billion ≈ $30.52 Million	0.507x	--

About Jw Pharmac

KO:001060 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$426.35 Million

₩629.13 Billion KRW

Market Cap Rank

#13176 Global

#382 in Korea

Share Price

₩27900.00

Change (1 day)

+1.64%

52-Week Range

₩20950.00 - ₩39050.00

All Time High

₩75306.05